Altman, D. G., Flora, J. A., Fortmann, S. P., & Farquhar, J. W.The cost-effectiveness of three smoking cessation programs. American Journal of Public Health, 1987, 77, 162–65.
Birch, S., & Donaldson, C.Applications of cost-benefit analysis to health care. Journal of Health Economics, 1987, 6, 211–25.
Boyle, M. H., Torrance, G. W., Sinclair, J. C., & Horwood, S. P.Economic evaluation of neonatal intensive care of very-low-birth-weight infants. New England Journal of Medicine, 1983, 308, 1330–37.
Dao, T. D.Cost-benefit and cost-effectiveness analysis of drug therapy. American Journal of Hospital Pharmacy, 1985, 42, 791–802.
Drummond, M. F., Smith, T. G., & Wells, N.Economic evaluation in the development of medicines. London: Office of Health Economics, 1988.
Drummond, M. F., & Shannon, H. S.Economic aspects of risk assessment in clinical safety. Science of the Total Environment, 1986, 51, 8 81–124.
Drummond, M. F. Methods for economic appraisal of health technology. In Drummond, M. F. (ed.), Economic appraisal of health technology in the European Community. Oxford: Oxford University Press, 1987, 15–47.
Drummond, M. F.Principles of economic appraisal in health care. Oxford: Oxford University Press, 1980.
Eisenberg, J. A., & Kitz, D. S.Savings from outpatient antibiotic therapy for osteomyelitis: Economic analysis of a therapeutic strategy. Journal of the American Medical Association, 1986, 255, 1584–88.
Eisenberg, J. A.New drugs and clinical economics: analysis of cost effectiveness in the assessment of pharmaceutical innovations. Review of Infectious Diseases, 1984, 6(suppl), S905–08.
Eisenberg, J. M., Glick, H., Hillman, A. L. et al. Measuring the economic impact of penoperative total parenteral nutrition: Principles and design. American Journal of Clinical Nutrition, 1988, 47, 382–91.
Evans, R. W., Manninen, D. L., Overcast, T. D. et al. The National Heart Transplantation Study: Final report. Seattle, WA: Battelle Human Affairs Research Centers, 1984.
Finkler, S. A.The distinction between cost and charges. Annals of Internal Medicine, 1982, 96, 102–09.
Garrison, L. P. Overview of cost analysis. In Evans, R. W. et al. (eds.), The National Heart Transplantation Study: Final report. Seattle, WA: Battelle Human Affairs Research Centers, 1984, 27, 1–21.
Guyatt, G., Drummond, M., Feeny, D. et al. Guidelines for the clinical and economic evaluation of health care technologies. Social Science and Medicine, 1986, 22, 393–408.
Hallstrom, A., Eisenberg, M. S., & Bergner, L.Modeling of the effectiveness and cost- effectiveness of an emergency service system. Social Science and Medicine, 1981, 15, 13–17.
Hodgson, T. A., & Meiners, M. R.Cost-of-illness methodology: A guide to current practices and procedures. Milbank Memorial Fund Quarterly/Health and Society, 1982, 60, 429–57.
Kupperman, M., Luce, B. et al. An analysis of the cost-effectiveness of the implantable cardiac defibrillator. Circulation, 1990, 81, 91–100.
Lannin, D. R., Silverman, J. F., Pories, W. J., & Walker, C.Cost-effectiveness of fine needle biopsy of the breast. Annals of Surgery, 1986, 203, 474–80.
Lubeck, D. P., Spitz, P. W., Fries, J. F. et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis and Rheumatism, 1986, 29, 488–93.
Luce, B.The implications of cost-effectiveness analysis of medical technology. Background paper #1: Methodological issues and literature review. Washington, DC: Office of lèchnology Assessment, 1980.
Mathews, A. & Bailie, G. R.Clinical pharmacokinetics, toxicity, and cost-effectiveness analysis of aminoglycosides and aminoglycoside dosing services. Journal of Clinical Pharmacology and Therapeutics, 1987, 12, 273–91.
Muller, A., & Reutzel, T. J.Willingness to pay for reduction in fatality risk: An exploratory survey. American Journal of Public Health, 1984, 74, 808–12.
Oster, G., Tuden, R. L., & Colditz, G. A.Prevention of venous thromboembolism after general surgery: Cost-effectiveness analysis of alternative approaches to prophylaxis. American Journal of Medicine, 1987, 82, 889–99.
Oster, G., & Epstein, A. M.Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease: The case of cholestyramine. Journal of the American Medical Association, 1987, 258, 2381–87.
Petitti, D. B.Competing technologies: Implications for the costs and complexity of medical care. New England Journal of Medicine, 1986, 315, 1480–83.
Russell, L.Evaluating preventive care. Washington, DC: Brookings Institute, 1987.
Schoenbaum, S. C., McNeil, B. J. & Kavet, J.The swine-influenza decision. New England Journal of Medicine, 1976, 295, 759–65.
Snider, D. E., Caras, G. J., & Koplan, J. P.Preventive therapy with isoniazid. Journal of the American Medical Association, 1986, 255, 1579–83.
Simon, D. G.A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation. Medical Decision Making, 1986, 6, 199–207.
Sinclair, J. C., TorranceG. W., G. W.,Boyle, M. H. et al. Evaluation of neonatal intensive care programs. New England Journal of Medicine, 1981, 305, 489–94.
Stason, W. B.Economics in hypertension management: Cost and quality trade-offs. Journal of Hypertension, 1987, 5(suppl.), S55–59.
Stason, W. B., & Weinstein, M. C.Public-health rounds at the Harvard School of Public Health. New England Journal of Medicine, 1977, 296, 732–46.
Torrance, G. W., & Zipursky, A.Cost-effectiveness of antepartum prevention of Rh immunization. Clinics in Perinatology, 1984, 11, 267–81.
Torrance, G. W., Stoddart, G. L., Drummond, M. F., & Gafni, A.Cost-benefit analysis versus cost-effectiveness analysis for the evaluation of long-term care programs. Health Services Research, 1981, 16, 474–76.
Van, Citters R. L., Bauer, C. B., Christopherson, L. K. et al. , Artificial heart and assist devices: Directions, needs, costs, societal, and ethical issues. Artificial Organs, 1985, 9, 375–415.
Warner, K. E., & Luce, B. R.Cost-benefit and cost-effectiveness analysis in health care: Principles, practice, and potential. Ann Arbor, MI: Health Administration Press, 1982.
Washington, A. E., Browner, W. S., & Korenbrot, C. C.Cost-effectiveness of combined treatment for endocervical gonorrhea. Journal of the American Medical Association, 1987, 257, 2056–60.
Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.
Weinstein, M. C., & Stason, W. B.Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annual Review of Public Health, 1985, 6, 41–63.
Weinstein, M. C., Read, J. L., MacKay, D. N. et al. , Cost-effective choice of antimicrobial therapy for serious infections. Journal of General Internal Medicine, 1986, 1, 351–63.
Weinstein, M. C., & Stason, W. B.Cost-effectiveness of coronary artery bypass surgery. Circulation, 1982, 66(suppl. III), 52–66.
Weisbrod, B. A., Test, M. A., & Stein, L. I.Alternative to mental hospital treatment II. Economic benefit-cost analysis. Archives of General Psychiatry, 1980, 37, 400–05.
Woodward, E. G., & Drummond, M. F.Cost effectiveness in a hospital contact lens department. Ophthalmic Physiology and Optometry, 1984, 2, 161–67.
Zeckhauser, R.Procedures for valuing lives. Public Policy, 1975, 23, 419–64.